关注
Ying-Hsia Chu
标题
引用次数
引用次数
年份
Clinicopathologic features of kinase fusion-related thyroid carcinomas: an integrative analysis with molecular characterization
YH Chu, LJ Wirth, AA Farahani, V Nosé, WC Faquin, D Dias-Santagata, ...
Modern Pathology 33 (12), 2458-2472, 2020
832020
Clinicopathologic and molecular characterization of NTRK-rearranged thyroid carcinoma (NRTC)
YH Chu, D Dias-Santagata, AA Farahani, B Boyraz, WC Faquin, V Nosé, ...
Modern Pathology 33 (11), 2186-2197, 2020
812020
MicroRNA-21 and long non-coding RNA MALAT1 are overexpressed markers in medullary thyroid carcinoma
YH Chu, H Hardin, DF Schneider, H Chen, RV Lloyd
Experimental and molecular pathology 103 (2), 229-236, 2017
592017
Medullary thyroid carcinoma: recent advances including microRNA expression
YH Chu, RV Lloyd
Endocrine Pathology 27, 312-324, 2016
442016
Association of ABCB1 and FLT3 Polymorphisms with Toxicities and Survival in Asian Patients Receiving Sunitinib for Renal Cell Carcinoma
YH Chu, H Li, HS Tan, V Koh, J Lai, WM Phyo, Y Choudhury, ...
PLoS One 10 (8), e0134102, 2015
372015
A multigene assay identifying distinct prognostic subtypes of clear cell renal cell carcinoma with differential response to tyrosine kinase inhibition
Y Choudhury, X Wei, YH Chu, LG Ng, HS Tan, V Koh, AA Thike, E Poon, ...
European urology 67 (1), 17-20, 2015
312015
Clinical features and phylogenetic analysis of Coxsackievirus A9 in Northern Taiwan in 2011
YC Huang, YH Chu, TY Yen, WC Huang, LM Huang, AL Cheng, HY Wang, ...
BMC infectious diseases 13, 1-7, 2013
302013
Parathyroid neoplasms: immunohistochemical characterization and long noncoding RNA (lncRNA) expression
Q Yu, H Hardin, YH Chu, W Rehrauer, RV Lloyd
Endocrine Pathology 30, 96-105, 2019
262019
Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): Diagnostic updates and molecular advances
YH Chu, PM Sadow
Seminars in diagnostic pathology 37 (5), 213-218, 2020
222020
In situ hybridization: Introduction to techniques, applications and pitfalls in the performance and interpretation of assays
YH Chu, H Hardin, R Zhang, Z Guo, RV Lloyd
Seminars in diagnostic pathology 36 (5), 336-341, 2019
212019
Nuclear expression of AFF2 C-terminus is a sensitive and specific ancillary marker for DEK:: AFF2 carcinoma of the sinonasal tract
YJ Kuo, JS Lewis Jr, T Truong, YC Yeh, RD Chernock, C Zhai, YA Chen, ...
Modern Pathology 35 (11), 1587-1595, 2022
192022
Cytomorphologic features of NTRK‐rearranged thyroid carcinoma
K Viswanathan, YH Chu, WC Faquin, PM Sadow
Cancer cytopathology 128 (11), 812-827, 2020
192020
Long non-coding RNA expression in anaplastic thyroid carcinomas
Y Wang, H Hardin, YH Chu, K Esbona, R Zhang, RV Lloyd
Endocrine Pathology 30, 262-269, 2019
192019
The critical role of early dengue surveillance and limitations of clinical reporting–implications for non-endemic countries
JH Kao, CD Chen, ZR Tiger Li, TC Chan, TH Tung, YH Chu, HY Cheng, ...
PloS one 11 (8), e0160230, 2016
172016
Clinical utility and performance of an ultrarapid multiplex RNA-based assay for detection of ALK, ROS1, RET, and NTRK1/2/3 rearrangements and MET exon 14 skipping alterations
YH Chu, J Barbee, SR Yang, JC Chang, P Liang, K Mullaney, R Chan, ...
The Journal of Molecular Diagnostics 24 (6), 642-654, 2022
162022
In situ hybridization analysis of long non-coding RNAs MALAT1 and HOTAIR in gastroenteropancreatic neuroendocrine neoplasms
YH Chu, H Hardin, J Eickhoff, RV Lloyd
Endocrine pathology 30, 56-63, 2019
162019
Indications for elective neck dissection in cT1N0M0 oral cavity cancer according to the AJCC eight edition: A nationwide study
CY Chien, CP Wang, LY Lee, SR Lee, SH Ng, CJ Kang, JC Lin, SD Terng, ...
Oral Oncology 140, 106366, 2023
122023
Recent advances in the classification of low-grade papillary-like thyroid neoplasms and aggressive papillary thyroid carcinomas: evolution of diagnostic criteria
Z Guo, M Ge, YH Chu, S Asioli, RV Lloyd
Advances in anatomic pathology 25 (4), 263-272, 2018
122018
Kinase Fusion–Related Thyroid Carcinomas: Towards Predictive Models for Advanced Actionable Diagnostics
YH Chu, PM Sadow
Endocrine pathology 33 (4), 421-435, 2022
102022
Clinical and molecular characteristics of East Asian patients with von Hippel–Lindau syndrome
M Wong, YH Chu, HL Tan, H Bessho, J Ngeow, T Tang, MH Tan
Cancer Communications 35 (1), 1-6, 2016
92016
系统目前无法执行此操作,请稍后再试。
文章 1–20